DOSE OF REALITY: DEBUNKING BIG PHARMA’S SUPPLY CHAIN BLAME GAME

08-14-2020 Blog Posts

Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering Drug Prices to Evade Responsibility and Boost Their Bottom Line Big Pharma has long tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at others in the drug supply chain. Drug companies, in particular, have […]

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB

08-6-2020 Blog Posts

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall Street Expectations After 2020 Price Hikes In a final round of second quarter earnings reports, another Big Pharma giant announced they surpassed earnings expectations after hiking prices on American patients. Bristol-Myers Squibb reported sky-high profits after hiking prices on American patients earlier […]

DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS

08-3-2020 Blog Posts

Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A Drug Company Idea The Origins of a Big Pharma Bailout Would you be surprised to learn a controversial idea to hand Big Pharma a more than $100 billion bailout while increasing Medicare premiums and costing taxpayers billions originated with a Big Pharma company? […]

BIG PHARMA EARNINGS WATCH: ABBVIE & MERCK

07-31-2020 Blog Posts

Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations After Price Hikes Two more Big Pharma giants announced Friday they surpassed earnings expectations after hiking prices on American patients. AbbVie and Merck both reported sky-high profits after hiking prices on American patients earlier this year. AbbVie Sales increased to $10.4 billion compared to […]

Big Pharma Earnings Watch: AstraZeneca & Eli Lilly

07-31-2020 Blog Posts

Brand Name Drug Companies See Soaring Profits After Hiking Prices Today, brand name drug giants AstraZeneca and Eli Lilly announced rising profits for the second quarter of 2020 – topping analysts’ expectations. AstraZeneca AstraZeneca reported a net profit of $756 million, up from $130 million for the same period a year earlier. Sales rose eight […]

BIG PHARMA EARNINGS WATCH: SANOFI

07-29-2020 Blog Posts

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant Sanofi topped earnings expectations while continuing to hike prices, new second-quarter earnings show. Sanofi beat earnings expectations this quarter and reported a net profit jump to $8.9 billion. Strong growth this quarter was driven by eczema and asthma drug Dupixent. Strong Q2 […]

BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN

07-29-2020 Blog Posts

Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New second quarter earnings reports released yesterday from Big Pharma giants Pfizer and Amgen demonstrate yet again that price hikes continue to support big time profits for brand name drug companies. Both pharmaceutical manufacturers beat Wall Street expectations for the second quarter of 2020. Pfizer […]

THEY SAID IT! COVERAGE HIGHLIGHTS REVIVED REBATE RULE AN UNWORKABLE BIG PHARMA BAILOUT

07-28-2020 Blog Posts

Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers, Support from Drug Companies and Poison Pill Provision On Friday, the administration announced the revival of a policy known as the Rebate Rule via executive order. The Rebate Rule was previously withdrawn by the White House amid concerns that the measure would hike premiums […]

THEY SAID IT: GOP AND CONSERVATIVE LEADERS CONCERNED WITH NEGATIVE IMPACT OF REBATE RULE

07-22-2020 Blog PostsPress Release

HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Conservative Commentators Raised Doubts on Premium Increases, Cost to Taxpayers and Bailout for Big Pharma Reports this week indicate the administration may reboot a policy known as the Rebate Rule. The Rebate Rule was previously withdrawn by the White House amid concerns, on both sides of the […]

BIG PHARMA EARNINGS WATCH: NOVARTIS

07-22-2020 Blog PostsPress Release

Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.